Validation of the Brazilian version of Chronic Liver Disease Questionnaire

Show simple item record

dc.contributor.author Mucci, Samantha [UNIFESP]
dc.contributor.author Citero, Vanessa de Albuquerque [UNIFESP]
dc.contributor.author Gonzalez, Adriano Miziara [UNIFESP]
dc.contributor.author Geocze, Luciana [UNIFESP]
dc.contributor.author Geocze, Stephan [UNIFESP]
dc.contributor.author Lopes Filho, Gaspar de Jesus [UNIFESP]
dc.contributor.author De Marco, Mario Alfredo [UNIFESP]
dc.contributor.author Parise, Edison Roberto [UNIFESP]
dc.contributor.author Nogueira Martins, Luiz Antonio [UNIFESP]
dc.date.accessioned 2016-01-24T14:31:11Z
dc.date.available 2016-01-24T14:31:11Z
dc.date.issued 2013-02-01
dc.identifier http://dx.doi.org/10.1007/s11136-012-0138-2
dc.identifier.citation Quality of Life Research. Dordrecht: Springer, v. 22, n. 1, p. 167-172, 2013.
dc.identifier.issn 0962-9343
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/35921
dc.description.abstract Purpose the aim of this study was to validate the Chronic Liver Disease Questionnaire (CLDQ) for use in Brazilian population.Method A total of 200 patients with chronic liver disease and varying disease severity answered a socio-demographic questionnaire, t CLDQ, and the Medical Outcome Study Short Form 36 (SF-36). Patients returned in 1-15 days to answer CLDQ again. the Cronbach's alpha of the total CLDQ score was 0.95 and fluctuated between 0.69 and 0.83 in its six domains.Results the intra-class correlation between total CLDQ scores in two evaluations was 0.97 and in all domains was >0.93. CLDQ was moderately correlated with the SF-36, 0.63 (total CLDQ vs. vitality, SF-36), 0.62 (CLDQ and mental health, SF-36), 0.62 (preoccupation, CLDQ, vs. General Health, SF-36), 0.59 (fatigue, CLDQ, vs. vitality, SF-36), 0.59 (activity, CLDQ, vs. vitality, SF-36), and 0.59 (fatigue, CLDQ, vs. mental health, SF-36). the highest scores were found in non-cirrhotic group. Child A patients had higher average scores than Child B and C groups in all domains, while patients with MELD <15 scored higher than patients with MELD >= 15.Conclusion CLDQ-BR was validated in Brazilian population and was appropriate for use in patients with liver disease of different etiologies and degrees of severity. en
dc.format.extent 167-172
dc.language.iso eng
dc.publisher Springer
dc.relation.ispartof Quality of Life Research
dc.rights Acesso restrito
dc.subject Quality of life en
dc.subject Chronic liver disease en
dc.subject Validation en
dc.subject CLDQ en
dc.subject MELD en
dc.title Validation of the Brazilian version of Chronic Liver Disease Questionnaire en
dc.type Artigo
dc.rights.license http://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.description.affiliation Universidade Federal de São Paulo, Dept Psychiat, São Paulo, Brazil
dc.description.affiliation Universidade Federal de São Paulo, Dept Surg Gastroenterol, São Paulo, Brazil
dc.description.affiliation Universidade Federal de São Paulo, Dept Clin Gastroenterol, São Paulo, Brazil
dc.description.affiliationUnifesp Universidade Federal de São Paulo, Dept Psychiat, São Paulo, Brazil
dc.description.affiliationUnifesp Universidade Federal de São Paulo, Dept Surg Gastroenterol, São Paulo, Brazil
dc.description.affiliationUnifesp Universidade Federal de São Paulo, Dept Clin Gastroenterol, São Paulo, Brazil
dc.identifier.doi 10.1007/s11136-012-0138-2
dc.description.source Web of Science
dc.identifier.wos WOS:000315279300020



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account